US President-elect Trump issued a document saying that the resignation of Christopher Babers, director of the Federal Bureau of Investigation (FBI), is a great day for the United States, accusing the FBI under his leadership of illegal actions, such as illegal search of his home, illegal impeachment and prosecution, which undermined the future of the United States. At the same time, it is believed that Kash Patel is the most qualified candidate to lead the FBI, and he is expected to confirm his leadership position to make the FBI great again. He also said that grassroots FBI personnel and the American people also hope to see these changes.Musk is worth $447 billion, nearly $200 billion behind Bezos. Tesla shares rose 5.9% on Wednesday to close at $424.77, a record high, surpassing the previous record of $409.97 set on November 4, 2021. According to the Bloomberg Billionaires Index, Musk's worth soared by $62.8 billion overnight to $447 billion, making him the first super-rich man on earth with a net worth of over $400 billion. Musk's current net worth is nearly $200 billion higher than that of the second-ranked Jeff Bezos, who is worth about $249 billion.OPENAI said that it is working hard to solve the current fault problem.
Citic Jiantou: We are optimistic about the investment opportunities in the pharmaceutical industry in 2025, focusing on the opportunities of new increase and industry integration. Citic Jiantou Securities reported on December 11th that looking forward to 2025, the reform policy in the pharmaceutical field has been normalized, and the most noteworthy incremental policy in the medical insurance field is to establish a diversified payment system. The medical field is about to usher in the reform of "deep water areas" such as salary system and graded diagnosis and treatment, which is in line with expectations on the whole. At the same time, the innovation of China's pharmaceutical industry has gradually stepped onto the international stage, some sub-sectors will be marginally improved, and industry integration will begin. We are optimistic about the investment opportunities in the pharmaceutical industry in 2025. It is suggested to focus on the new increase (innovation, going out to sea, marginal change) and industry integration opportunities.18 shares were rated by brokers, and Yuhetian's target increased by 54.72%. On December 11th, a total of 18 shares were rated by brokers, and 6 of them announced their target prices. According to the highest target price, Yuhetian, Steady Medical Care and Fulongma ranked in the top, with increases of 54.72%, 19.96% and 17.62% respectively. Judging from the direction of rating adjustment, the ratings of 12 stocks remain unchanged and 6 stocks are rated for the first time. In addition, one stock attracted the attention of many brokers, and Hagrid Communications was ranked in the top number, with two brokers rating it respectively. Judging from the Wind industry to which the rated stocks are bought, the number of rated stocks for technical hardware and equipment, capital goods and materials II is the largest, with 4, 3 and 2 respectively.Huichuan Technology: The company has made great efforts to broaden the products and applications of six-axis robots, and the six-axis robots with small loads have achieved mass sales. Huichuan Technology said on the interactive platform that the company has made great efforts to broaden the products and applications of six-axis robots, and the six-axis robots with small loads have achieved mass sales, and the six-axis robots with medium and large loads have begun to form mass sales.
Survey: Most Japanese companies expect Trump 2.0 to damage the business environment. According to a survey in Reuters, nearly three-quarters of Japanese companies expect Trump's second US presidency to have a negative impact on the business environment of Japanese companies. The reasons for concern include the planned tariff increase and trade tensions. The manager of a machinery manufacturer wrote in the survey: "It is difficult to predict his policies, which makes it difficult for our client company to make investment decisions"; Although 73% of the respondents said that Trump's second entry into the White House will not have a favorable impact on their business environment, the rest of the respondents expect a positive impact, including the expectation that domestic demand in the United States will expand through tax cuts, and energy and environmental policies may also be revised; When asked what measures they would take if Trump raised tariffs, two-thirds of the respondents said their business strategy was unlikely to change, 22% said they would cut costs, and 8% said they would work hard to expand their cultivation in markets outside the United States.South Korean President Yin Xiyue made a public speech: I will fight with the public until the last moment.Yuncong Technology: "The R&D team of large-scale model agent products is basically dissolved" is all false information. Yuncong Technology said on the interactive platform that the company's R&D team is stable at present, and a rigorous and meticulous hierarchical division of labor system has been established for the research and development of large-scale model related products. The configuration of R&D echelon will be flexibly adjusted according to the continuous evolution of large model technology and the changes of market demand of agent products. The statements of "the No.1 position of the big model algorithm" and "the R&D team of the big model agent product is basically dissolved" mentioned in the question are false information, and the company reserves the right to pursue legal responsibility for this. The company has been unswervingly promoting the research and product development of large-scale model and agent-related technologies.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14